Results 221 to 230 of about 10,762,797 (269)

Exploring the influence of lactoferrin on wound healing and related signaling pathways: a systematic review

FEBS Open Bio, EarlyView.
Lactoferrin promotes wound healing by activating MAPK, PI3K/Akt, and extracellular matrix pathways, enhancing fibroblast remodeling, proliferation, and re‐epithelialization. These mechanisms highlight its therapeutic potential in inflammation control, tissue repair, and remodeling.
Morgana Lüdtke Azevedo, Kátia Cristiane Hall, Matheus dos Santos Fernandez, Geovanna Peter Corrêa, Rafael Guerra Lund   +4 more
wiley   +1 more source

Incidence of and Risk Factors for Tuberculosis Among Patients Treated for Hepatitis C: a Population-based Cohort Study. [PDF]

Open Forum Infect Dis
Korinteli T, Tukvadze N, Chincharauli M, Avaliani Z, Kipiani M, Getia V, Magee MJ, Blumberg HM, Baliashvili D.   +8 more
europepmc   +1 more source

Dose‐dependent hepatotoxicity of hydrogen peroxide in HepG2 cells and its modulation by CYP450 induction

FEBS Open Bio, EarlyView.
NMR metabolomics revealed concentration‐dependent metabolic perturbations in HepG2 cells exposed to H2O2. Rifampicin pretreatment enhanced metabolic competence, attenuated toxin‐induced alterations and produced metabolite profiles more consistent with human liver physiology, supporting the use of CYP450‐induced HepG2 models for improved in vitro ...
Maren Jinks, Garth L. Maker, Emily C. Davies, Berin A. Boughton, Samantha Lodge   +4 more
wiley   +1 more source

多変量解析によるTreatment Priority Indexの評価

, 1993
openaire   +1 more source

Novel Compounds as CDK4 Inhibitors for Treating Breast Cancer. [PDF]

ACS Med Chem Lett
Sabnis RW.
europepmc   +1 more source

Evaluating the effect of γ‐oryzanol on MASLD pathology using a medaka fish model

FEBS Open Bio, EarlyView.
This study explores a liver disease called MASLD, which is increasing worldwide and can lead to serious damage. Researchers used medaka fish instead of rodents to test a food compound, γ‐oryzanol. Fish fed this compound had less liver fat and healthier gut bacteria.
Yukako Ito, Haduki Asano, Ayano Ueki, Joe Sakamoto, Yasuhiro Kamei, Hayato Tokumoto, Ayaka Yazawa, Shigeki Kamitani   +7 more
wiley   +1 more source

Use of real-world evidence in the U.S. Food and Drug Administration and the European Medicines Agency approvals of oncology products supported by single-arm trials (2022-2025). [PDF]

Oncologist
Su L, Chen L, Mamtani R, Betigeri S, Hubbard R, Burcu M.   +5 more
europepmc   +1 more source

Evaluating the Association Between Patient Priorities and ICU Care Delivery in Adults Receiving Mechanical Ventilation. [PDF]

Chest
Donovan KA, Polley M, Palmer G, Hanlon BM, Stalter LN, Donnelly HK, Wunderink RG, Gao CA, Kruser JM, NU SCRIPT Study Investigators.   +9 more
europepmc   +1 more source

Tuberculosis preventive therapy in Sierra Leone: early implementation gaps and lessons learned. [PDF]

Public Health Action
Farma-Grant L, Kanu JS, Molleh B, Kamara IF, Kamara ARY, Sesay N, Lahai WK, Fofanah B, Falama MA, Offe Amponsah OK, Mahmoud M, Grant DS, Siatty Y, Zachariah R, Koroma J, Mustapha M, Sesay T, Kenneh S.   +17 more
europepmc   +1 more source

Development and validation of a precision treatment rules for first-line antipsychotic recommendations in first episode psychosis jointly incorporating effectiveness, side effects and patient preferences. [PDF]

Transl Psychiatry
Krakowski K, Oliver D, Arribas M, Logeswaran Y, de Micheli A, Patel R, Stahl D, Fusar-Poli P.   +7 more
europepmc   +1 more source